Baillie Gifford & Co’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $1.14M | Sell |
|
|||||
|
2022
Q3 | $891M | Sell |
|
|||||
|
2022
Q2 | $918M | Buy |
|
|||||
|
2022
Q1 | $1.23B | Sell |
|
|||||
|
2021
Q4 | $1.38B | Buy |
|
|||||
|
2021
Q3 | $1.22B | Buy |
|
|||||
|
2021
Q2 | $1.13B | Buy |
|
|||||
|
2021
Q1 | $1.1B | Buy |
|
|||||
|
2020
Q4 | $986M | Buy |
|
|||||
|
2020
Q3 | $816M | Buy |
|
|||||
|
2020
Q2 | $687M | Buy |
|
|||||
|
2020
Q1 | $396M | Buy |
|
|||||
|
2019
Q4 | $464M | Buy |
|
|||||
|
2019
Q3 | $479M | Buy |
|
|||||
|
2019
Q2 | $578M | Buy |
|
|||||
|
2019
Q1 | $309M | Buy |
|
|||||
|
2018
Q4 | $347M | Buy |
|
|||||
|
2018
Q3 | $362M | Sell |
|
|||||
|
2018
Q2 | $862M | Buy |
|
|||||
|
2018
Q1 | $595M | Buy |
|
|||||
|
2017
Q4 | $365M | Sell |
|
|||||
|
2017
Q3 | $333M | Buy |
|
|||||
|
2017
Q2 | $283M | Buy |
|
|||||
|
2017
Q1 | $209M | Buy |
|
|||||
|
2016
Q4 | $66.3M | Buy |
|
|||||
|
2016
Q3 | $74M | Sell |
|
|||||
|
2016
Q2 | $65.4M | Sell |
|
|||||
|
2016
Q1 | $65.2M | Buy |
|
|||||
|
2015
Q4 | $25.9M | Buy |
|